Synthesis and antioxidant evaluation of some novel orthohydroxypyridine- 4-one iron chelators

Research in Pharmaceutical Sciences

Volumn 7, Issue 3, 2012, Pages 171-179

  Mohammadpour, M ^a   Sadeghi, A ^a   Fassihi, A ^a   Saghaei, L ^a   Movahedian, A ^a   Rostami, M ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant activity; Iron chelating activity; Ortho hydroxypyridine 4 one; Radical scavenging activity

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 5 (BENZYLOXY) 1 METHYL 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE; 5 (BENZYLOXY) 2 (HYDROXYMETHYL) 1 METHYLPYRIDIN 4 (1H) ONE; 5 (BENZYLOXY) 2 (HYDROXYMETHYL) 4H PYRAN 4 ONE; 5 (BENZYLOXY) 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE; 5 BENZYLOXY 1 METHYL 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE OXIME; 5 BENZYLOXY 2 (HYDROXYMETHYL)PYRIDIN 4(1H) ONE; 5 BENZYLOXY 2 [(2 HYDROXYPHENYLIMINO)METHYL] 1 METHYLPYRIDIN 4 (1H) ONE; 5 BENZYLOXY 2 [(2 HYDROXYPHENYLIMINO)METHYL]PYRIDIN 4 (1H) ONE; 5 BENZYLOXY 2 [(PHENYLAMINOIMINO)METHYL] 1 METHYLPYRIDIN 4 (1H) ONE; 5 BENZYLOXY 2 [(PHENYLAMINOIMINO)METHYL]PYRIDIN 4 (1H) ONE; 5 BENZYLOXY 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE OXIME; 5 HYDROXY 1 METHYL 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE OXIME; 5 HYDROXY 2 [(2 HYDROXYPHENYLAMINO)METHYL] 1 METHYLPYRIDIN 4 (1H) ONE; 5 HYDROXY 2 [(2 HYDROXYPHENYLAMINO)METHYL]PYRIDIN 4 (1H) ONE; 5 HYDROXY 2 [(PHENYLAMINOIMINO)METHYL] 1 METHYLPYRIDIN 4 (1H) ONE; 5 HYDROXY 2 [(PHENYLAMINOIMINO)METHYL]PYRIDIN 4 (1H) ONE; ANTIOXIDANT; FREE RADICAL; HYDROGEN PEROXIDE; IRON CHELATING AGENT; PYRIDINE DERIVATIVE; SCAVENGER; UNCLASSIFIED DRUG;

5 HYDROXY 4 OXO 1,4 DIHYDROPYRIDINE 2 CARBALDEHYDE OXIME; ANTIOXIDANT ACTIVITY; ARTICLE; COMPLEX FORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; FENTON REACTION; IC 50; IRON CHELATION;

EID: 84873364474     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Guelman LR, Pagotto RM, Di Toro CG, Zieher LM. Deferoxamine antioxidant activity on cerebellar granule cells γ-irradiated in vitro. Neurotoxicol Teratol. 2004;26:477-483.
2. Sjödin B, Hellsten-Westing Y, Apple FS. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med. 1990;10:236-254.
3. Reeder BJ, Hider RC, Wilson MT. Iron chelators can protect against oxidative stress through ferryl heme reduction. Free Radic Biol Med. 2004;44:264- 273.
4. Loganathan JK, Gunasundari D, Hemalatha M, Shenbhagaram R, Kaviyarasan V. Antioxidant and phytochemical potential of wild edible mushroom Termitomyces reticulatus: individual cap and stipe collected from eastern part of India. IJPSR. 2010;1:62-72.
5. Palmer C, Metals and Oxidative Damage in Neurological Disorders. New York, Plenum Press, 1997. p. 205-236.
6. Hider RC. Potential protection from toxicity by oral iron chelators. Toxicol Lett. 1995;82/83:961-967.
7. van der Kraaij AMM, van Eijk HG, Koster JF. Prevention of postischemic cardiac injury by the orally active iron chelator 1, 2 -Dimethyl-3 - Hydroxy- 4-Pyridone (L1) and the antioxidant (+)- cyanidanol-3. Circulation 1989;80:158-164.
8. Velasco-Sánchez D, Aracil A, Montero R, Mas A, Jiménez L, O'Callaghan M, et al. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia. Cerebellum, 2011;10:1-8.
9. van Acker SA, van Balen GP, van den Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol, 1998;56:935-943.
10. Zheng H, Weiner LM, Bar-Am O. Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotec-tion in Alzheimer's, Parkinson's, and other neurodegenerative diseases. Bioorg Med Chem. 2005;13:773-783.
11. Kayyali R, Pannala AS, Khodr H, Hider RC. Comparative radical scavenging ability of bidentate iron (III) chelators. Biochem Pharmacol. 1998;55:1327-1332.
12. David B, Nat M, Suneel G, Alan P, Richard P, Craig M. Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents. PAT-WO9923075. 1999.
13. Schugar H, Green DE, Bowen ML, Scott LE, Storr T, Böhmerle K, et al. Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. Angew Chem. 2007;119:1746-1748.
14. Streater M, Taylor PD, Hider RC, Porter J. Novel 3- hydroxy-2(1H)- pyridinones. Synthesis, iron (III)- chelating properties and biological activity. J Med Chem. 1990;33:1749-1755.
15. Ma YM, Luo W, Quinn PJ, Zudong L, Hider RC. Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors. J Med Chem. 2004;47:6349-6362.
16. Becker HD. The conversion of kojic acid into comenaldehyde and comenic acid. Acta Chem Scand. 1962;16:78-82.
17. Blois MS. Antioxidant determinations by the use of a stable free radical. Nature. 1958;181:1199-1200.
18. Ruch RJ, Cheng SJ, Klaunig JE. Prevention of cytotoxicity and inhibition of intracellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis. 1989;10:1003-1008.
19. Dinis TCP, Maderia VMC, Almeida LM. Action of phenolic derivatives (acetaminophen, salicylate and 5-Amino salycilate) as inhibitor of membrane lipid peroxidation and as peroxyl radical scavengers. Arch Bichem Biophys 1994;315:161-169.
20. Amarowicz R, Pegg RB, Rahimi-Moghaddam P, Barl B, Weil JA. Free-radical scavenging capacity and antioxidant activity of selected plant species from the Canadian prairies. Food Chemistry. 2004;84:551-562.
21. Siddhuraju P, Becker K. The antioxidant and free radical scavenging activities of processed cowpea (Vigna Unguiculata (L.) Walp.) seed extracts. Food Chemistry. 2007;101:10-19.
22. Halliwell B, Gutteridge JMC, Free Radicals in Biology and Medicine. 4th ed. Oxford, Clarendon Press. 2006. p. 419-420.
23. Gordon MH. The mechanism of antioxidant action in vitro. In: B.J.F. Hudson. Food Antioxidants. London. Elsevier Applied Science. 1990. p. 1-18.